Atlas Trials

Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway

Clinical trial NCT01601184 · TERMINATED

Trial details

NCT number
NCT01601184
Sponsor
Centre Leon Berard
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Histologically Confirmed MedulloblastomaActivation of the Sonic Hedgehog (SHH) Pathway
Start date
2012-06-01
Primary completion
2017-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.